GSK to set up Rs.200mn plant to produce Iodex and Eno locally

04 Dec 2012 - {{hitsCtrl.values.hits}}

GlaxoSmithKline (GSK), one of the world’s largest research based pharmaceutical and healthcare companies in the world is planning to invest Rs.200 million Sri Lanka to set up a manufacturing plant to locally produce its well known pain relief balm and gastritis treatment pill.

The state-of-the art facility will be inaugurated in the first quarter of 2013 and will produce two of its well known brands, Iodex and Eno.

GSK has been operating in Sri Lanka since 1958, marketing pharmaceutical and healthcare products.

Other

GSK to set up Rs.200mn plant to produce Iodex and Eno locally

Most Popular Articles

Sri Lanka’s exports surpass US$9 billion in first half of 2026

Sri Lanka’s IMF reserve target comes under pressure: KPMG

Sri Lanka explores local gold refinery as IMF regulations delay import tax relief for jewellers

CSE ends lower as turnover falls to year’s lowest, ASPI holds key support

HMD introduces latest range of feature phones to Sri Lanka

CSE opens the week lower as broad-based selling offsets strong institutional activity

Latest News

Singer “Chili” fined for attempted assault on police officers

Sri Lanka’s exports surpass US$9 billion in first half of 2026

China ready to work with Sri Lanka to build strategic trust: Chinese Ambassador

Wildlife holiday bungalows to be upgraded

Toxic alcohol addiction changes brain chemistry: Psychotherapist